Menopur

Menotrophin, the active ingredient in Menopur, is a gonadotropin (FSH/LH) preparation presented as an injectable solution for subcutaneous use. It stimulates ovarian follicular development and is used in women with infertility. GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menopur acts on the reproductive hormone pathway to support follicular growth and ovulation in women with infertility. - Induction of ovulation in anovulatory women: promotes follicular growth to achieve ovulation. - Controlled ovarian stimulation for assisted reproductive technologies (IVF, IUI): enhances multiple follicle development for egg retrieval. - Treatment of infertility associated with hypogonadotropic hypogonadism: provides exogenous FSH and LH activity to restore normal ovarian function.

Menopur may cause a range of adverse reactions, most of which are related to its hormonal activity and injection route.

Common Side Effects: - Injection site reactions: redness, swelling, or pain at the injection site. - Mild ovarian hyperstimulation syndrome: abdominal discomfort, bloating, or mild weight gain. - Headache: occasional mild to moderate intensity. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome: rapid weight gain, shortness of breath, electrolyte imbalance, and possible hospitalization. - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Allergic reactions: rash, urticaria, or anaphylaxis.

Before initiating Menopur, clinicians should consider several safety measures. - Patient selection: assess ovarian reserve and individual risk factors for hyperstimulation. - Monitoring: perform regular ultrasound and estradiol measurements to detect overstimulation early. - Concomitant medications: avoid combining with other gonadotropins unless specifically directed. - Pregnancy considerations: discontinue Menopur once pregnancy is confirmed. - Contraindications: not for use in patients with ovarian cysts, estrogen‑dependent tumors, or uncontrolled thyroid disease. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - GnRH agonists or antagonists: concurrent use may alter ovarian response; coordinate timing under specialist supervision. - Thyroid hormone therapy: uncontrolled thyroid disease can affect treatment efficacy; achieve euthyroid status before starting. - High‑dose corticosteroids: may increase risk of ovarian hyperstimulation; monitor closely.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may suppress endogenous gonadotropins; ensure appropriate washout period before Menopur. - Anticoagulants: risk of thrombosis may be heightened with ovarian hyperstimulation; monitor coagulation parameters. - Diuretics: may mask fluid retention signs of hyperstimulation; observe patient closely.